Company / Tangible Book Value per Share
Halozyme Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$4.32
FY2025
5-year range
-$4.32 / $0.68
FY2021-FY2025
Trend
-932.5%
vs FY2024
Sector context
#200 of 209
Health Care
What the data says
Tangible Book Value per Share changed -932% YoY in FY2025, a notable deviation from the 9-year average annual change of -99%.
Based on SEC 10-K filings.
-4.32 in FY2025.
Declined from $-2.46 to $-4.32 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 209This company -$4.32 Sector average $119.74
▼
-103.6% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 932.5% year-over-year.
- Ranks #200 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2020.
Company context
Key Data Points
- Strong profit margin: 47.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 118.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.32 | -932.5% |
| FY2024 | -$0.42 | +83.0% |
| FY2023 | -$2.46 | -41.6% |
| FY2022 | -$1.74 | -356.0% |
| FY2021 | $0.68 | -62.7% |
| FY2020 | $1.82 | +26.4% |
| FY2019 | $1.44 | -17.4% |
| FY2018 | $1.74 | +8.3% |
| FY2017 | $1.61 | +398.6% |
| FY2016 | $0.32 | +302.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026